The race to launch the vaccine at the earliest has been intensified amidst the growing cases of Corona worldwide including India
The race to launch COVID-19 vaccine has been accelerated as soon as possible in the growing cases of Corona around the world including India. Currently, Russia has claimed to have an edge in this race by launching a vaccine.
However, due to the question of scientists and different standards in different countries, the Russian vaccine may take a long time to reach the whole world. In India too, approval of the vaccine of another country may take time, because first those vaccines will be tried on patients in India.
Meanwhile, an official has said that the human trials of corona vaccine prepared by Oxford University have been far-reaching and now preparations for its production have also started. AstraZeneca could begin production of the Oxford COVID-19 vaccine in the first quarter of 2021, under an agreement between the Mexican and Argentine governments and the Drugmaker.
The official said the Phase III trial of the Corona vaccine will be completed by the end of December. Let us tell you that Oxford University of British together with the Swedish firm Astrazeneca is making the Corona vaccine.
According to the official, the Phase III trial has started in the US and Brazil. The first-stage trials of the corona vaccine responded well. It is not indicating any serious side effects. The trial of the Oxford University vaccine in India has been approved.
The Serum Institute of India (SII) has been approved by the Drug Controller General of India (DGCA) for the Serum Institute of India (SII) Second and Third Phase Human Trials of Oxford Vaccine in India. India is currently undergoing trials on 3 vaccines.
A vaccine has been developed by Oxford University in association with the Pune-based Serum Institute of India. Similarly, Bharat Biotech and Zydus Cadila Company have also separately Have prepared the vaccine.